General characteristics of the cohort
Overall cohort | N=81 363 | |
Age (years) (±SD) | 65 (11) | |
Sex, female (%) | 74 772 (91.9) | |
Menopause, n (% of female) | 71 654 (95.8) | |
Weight (±SD) | 62.2 (12.0) | |
Height (±SD) | 160 (8) | |
Concomitant treatment (%) | None | 69 616 (85.6) |
Treatment with adjuvant hormone therapy | 6264 (7.7) | |
Glucocorticoids ≥5 mg/day of prednisone equivalent for ≥3 months | 5483 (6.7) | |
Diseases (%) | None | 63 497 (78.0) |
Rheumatoid arthritis | 3817 (4.7) | |
Psoriatic arthritis | 992 (1.2) | |
Systemic lupus erythematosus | 384 (0.5) | |
Systemic sclerosis | 374 (0.5) | |
Other connective tissue diseases | 2571 (3.2) | |
Inflammatory bowel diseases | 1250 (1.5) | |
Multiple sclerosis | 335 (0.4) | |
Diabetes | 4184 (5.1) | |
Chronic pulmonary diseases | 2097 (2.6) | |
Severe physical handicap | 1058 (1.3) | |
Parkinson’s disease | 502 (0.6) | |
HIV infection | 302 (0.4) | |
Specialty of the physician entering patients’ data (%) | Rheumatology | 17 310 (21.3) |
Endocrinology | 26 278 (32.3) | |
Family care practitioner | 10 207 (12.5) | |
Internal medicine | 5757 (7.1) | |
Orthopedy | 5699 (7.0) | |
Physiatry | 5420 (6.7) | |
Gynaecologist | 2328 (2.9) | |
Other | 8364 (10.3) |